Olmesartan medoximil
Brand names,
Olmesartan medoximil
Analogs
Olmesartan medoximil
Brand Names Mixture
Olmesartan medoximil
Chemical_Formula
C29H30N6O6
Olmesartan medoximil
RX_link
http://www.rxlist.com/cgi/generic/benicar.htm
Olmesartan medoximil
fda sheet
Olmesartan medoximil
msds (material safety sheet)
Olmesartan medoximil
Synthesis Reference
No information avaliable
Olmesartan medoximil
Molecular Weight
558.585 g/mol
Olmesartan medoximil
Melting Point
175-180 oC
Olmesartan medoximil
H2O Solubility
No information avaliable
Olmesartan medoximil
State
Solid
Olmesartan medoximil
LogP
5.202
Olmesartan medoximil
Dosage Forms
Tablet
Olmesartan medoximil
Indication
For the treatment of hypertension
Olmesartan medoximil
Pharmacology
Olmesartan Medoxomil, a specific angiotensin II type 1 antagonist, is used alone or with other antihypertensive agents to treat hypertension. Unlike the angiotensin receptor antagonist losartan, olmesartan does not have an active metabolite or possess uricosuric effects. Blockade of the angiotensin II receptor inhibits the negative regulatory feedback of angiotensin II on renin secretion, but the resulting increased plasma renin activity and circulating angiotensin II levels do not overcome the effect of olmesartan on blood pressure.
Olmesartan medoximil
Absorption
Bioavailability is about 26%. Food does not affect the bioavailability of olmesartan.
Olmesartan medoximil
side effects and Toxicity
Symptoms of overdose include dehydration (dry mouth, excessive thirst, muscle pain or cramps, nausea and vomiting, weakness), dizziness, low blood pressure, and slow or irregular heartbeat.
Olmesartan medoximil
Patient Information
Olmesartan medoximil
Organisms Affected
Humans and other mammals